Rho-kinase and effects of Rho-kinase inhibition on the lower urinary tract.

Rho-kinase and effects of Rho-kinase inhibition on the lower urinary tract. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Rho-kinase and effects of Rho-kinase inhibition on the lower urinary tract. Abstract Text:

George J Christ,Karl-Erik Andersson,George J Christ,Karl-Erik Andersson,

Altered smooth muscle cell contractility/tone contributes, at least in part, to the lower urinary tract symptoms (LUTS) seen in men with benign prostatic obstruction (BPO). Accordingly, many of the therapies to date have focused largely on blockade of individual membrane receptors to diminish smooth muscle contractility and provide symptomatic relief. This pharmacologic approach has been associated with variable results, limited efficacy, and untoward side effects. Such limited clinical success is not surprising given the plethora of neurotransmitters, neuromodulators, and hormones that are now known to modulate LUT smooth muscle cell tone. In the pursuit of improved treatment options, more recent investigations have focused attention on intracellular signal transduction events that represent convergence points for membrane receptor activation. In particular, calcium sensitization and the role of the Rho-kinase pathway has received much attention. In this report, we review the literature on the role of the Rho-kinase pathway in the modulation of LUT smooth muscle cell tone. In short, the available data support an important role for Rho-kinase in the physiologic and pathophysiologic regulation of LUT smooth muscle cell tone. Rho-kinase inhibitors thus appear to represent a potentially attractive therapeutic possibility for the treatment of LUTS.

Rho-kinase and effects of Rho-kinase inhibition on the lower urinary tract. Publishing Authors By Initials

GJ Christ,KE Andersson,GJ Christ,KE Andersson,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Rho-kinase and effects of Rho-kinase inhibition on the lower urinary tract. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Neurourology and urodynamics

VOLUME: 26

Page Numbers: 948-54

Journal Abbreviation: Neurourol. Urodyn.

ISSN: 0733-2467

DAY: 26

MONTH: Oct

YEAR: 2007

Rho-kinase and effects of Rho-kinase inhibition on the lower urinary tract. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8303326

Rho-kinase and effects of Rho-kinase inhibition on the lower urinary tract. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Rho-kinase and effects of Rho-kinase inhibition on the lower urinary tract. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Rho-kinase and effects of Rho-kinase inhibition on the lower urinary tract.

AFFILIATION: Wake Forest Institute for Regenerative Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157, USA. gchrist@wfubmc.edu

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Neurourol Urodyn

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Rho-kinase and effects of Rho-kinase inhibition on the lower urinary tract Related Publications

• Assessment of bleeding after concomitant administration of antiplatelet and anticoagulant agents in lower limb arthroplasty.
• Bone Ingrowth Through Porous Titanium Granulate Around a Femoral Stem: Histological assessment in a six-month canine hemiarthroplasty model.
• Cardiac reserve in the transplanted heart: effect of a graft polymorphism in the beta1-adrenoceptor.
• Case-referent study of cystic ovaries as a risk indicator for twin calvings in dairy cows.
• Cluster of Salmonella Enteritidis in Sweden 2005-2006 - suspected source: almonds.
• Duplication of FGF3, FGF4, FGF19 and ORAOV1 causes hair ridge and predisposition to dermoid sinus in Ridgeback dogs.
• Effect of timing of dosing in relation to food intake on the pharmacokinetics of esomeprazole.
• GRAT--genome-scale rapid alignment tool.
• GTP bound to chloroplast thylakoid membranes is required for light-induced, multienzyme degradation of the photosystem II D1 protein.
• Improved survival rate for women with interval breast cancer - results from the breast cancer screening programme in Malmö, Sweden 1976-1999.
• Inclusion of regional poroelastic material properties better predicts biomechanical behavior of lumbar discs subjected to dynamic loading.
• Intracellular pathogens go extreme: genome evolution in the Rickettsiales.
• Knowledge of emergency management of avulsed teeth among young physicians and dentists.
• LUTS treatment: future treatment options.
• Lack of Pharmacokinetic Interaction between Esomeprazole and the Nonsteroidal Anti-Inflammatory Drugs Naproxen and Rofecoxib in Healthy Subjects.
• Loss-of-function mutation in carotenoid 15,15'-monooxygenase identified in a patient with hypercarotenemia and hypovitaminosis A.
• Multiple mechanisms to ameliorate the fitness burden of mupirocin resistance in Salmonella typhimurium.
• Muscarinic receptor antagonists for overactive bladder.
• Origin of mutations under selection: the adaptive mutation controversy.
• Outbreak of Salmonella Stanley in Sweden associated with alfalfa sprouts, July-August 2007.
• Pharmacokinetics of once-daily IV busulfan as part of pretransplantation preparative regimens: a comparison with an every 6-hour dosing schedule.
• Postoperative Melagatran/Ximelagatran for the Prevention of Venous Thromboembolism following Major Elective Orthopaedic Surgery : Effects of Timing of First Dose and Risk Factors for Thromboembolism and Bleeding Complications on Efficacy and Safety.
• Proteolytic processing and polarized secretion of tartrate-resistant acid phosphatase is altered in a subpopulation of metaphyseal osteoclasts in cathepsin K-deficient mice.
• Recurrence in patients with oral and oropharyngeal squamous cell carcinoma: human papillomavirus and other risk factors.
• Rho-kinase and effects of Rho-kinase inhibition on the lower urinary tract.
• Settlement size and fertility in the Nordic countries.
• Structural analysis of altered large-subunit loop-6/carboxy-terminus interactions that influence catalytic efficiency and CO2/O2 specificity of ribulose-1,5-bisphosphate carboxylase/oxygenase.
• The importance of an active ongoing debate in science.
• Treatment-resistant detrusor overactivity--underlying pharmacology and potential mechanisms.
• p16INK4a immunocytochemistry in liquid-based cervical cytology: is it feasible for clinical use?